Tbio TNIP1 TNFAIP3-interacting protein 1

Protein Summary

Description

Inhibits NF-kappa-B activation and TNF-induced NF-kappa-B-dependent gene expression by regulating A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG. Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcription. Increases cell surface CD4(T4) antigen expression. Involved in the anti-inflammatory response of macrophages and positively regulates TLR-induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosphorylation by SRC-family kinases. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. In case of infection, promotes association of IKBKG with Shigella flexneri E3 ubiquitin-protein ligase ipah9.8 p which in turn promotes polyubiquitination of IKBKG leading to its proteasome-dependent degradation and thus is perturbing NF-kappa-B activation during bacterial infection. This gene encodes an A20-binding protein which plays a role in autoimmunity and tissue homeostasis through the regulation of nuclear factor kappa-B activation. Mutations in this gene have been associated with psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]

Uniprot Accession IDs

• Q15025
• A4F1W8
• A4F1W9
• A4F1X2
• A4F1X4
• A4F1X5
• A4F1X6
• A4F1X7
• A4F1X9
• B7Z699
• E7EPY1
• E7ET96
• O76008
• Q05KP3
• Q05KP4
• Q6N077
• Q96EL9
• Q99833
• Q9H1J3

Gene Name

• TNIP1

Ensembl ID

• ENST00000315050
• ENSP00000317891
• ENSG00000145901
• ENST00000518977
• ENSP00000430971
• ENST00000520931
• ENSP00000429891
• ENST00000521591
• ENSP00000430760
• ENST00000522226
• ENSP00000428187
• ENST00000523200
• ENSP00000431105
• ENST00000523338
• ENSP00000428243
• ENST00000524280
• ENSP00000429912
• ENST00000610535
• ENSP00000483944
• ENST00000610874
• ENSP00000484665

Symbol

• KIAA0113
• NAF1
• VAN
• NAF1
• ABIN-1
• nip40-1

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
kinase perturbation	0.91
biological process	0.87
phenotype	0.86
transcription factor perturbation	0.8
disease perturbation	0.79

Protein Classes

No PANTHER Classes or DTO Classes found

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 118.47   (req: < 5)

Gene RIFs: 95   (req: <= 3)

Antibodies: 277   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 118.47   (req: >= 5)

Gene RIFs: 95   (req: > 3)

Antibodies: 277   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 16

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0